Form 4: Bausch & Lomb Executive Receives Stock Options and Restricted Stock Units

Luc Bonnefoy, President, Surgical at Bausch & Lomb, reports acquisition of stock options and restricted stock units.

Summary

• Luc Bonnefoy, President, Surgical at Bausch & Lomb Corp, filed a Form 4 on February 28, 2025.
• The report details changes in beneficial ownership due to the grant of restricted stock units (RSUs) and stock options.
• On February 26, 2025, Bonnefoy acquired 23,423 common shares through RSUs and disposed of 78,490 common shares.
• Additionally, Bonnefoy acquired 55,793 non-qualified stock options with an exercise price of $15.86.
• The RSUs vest in equal installments over three years from the grant date.
• The stock options also vest in equal installments over three years and expire ten years from the grant date.

Sentiment

Score: 7

Explanation: The sentiment is neutral to slightly positive. It reflects standard executive compensation practices, which are generally viewed favorably as they align management interests with shareholder value.

Positives

• The grant of RSUs and stock options aligns the executive's interests with the company's long-term performance.
• The vesting schedule encourages continued service and commitment from the executive.

Future Outlook

The document does not contain specific forward-looking statements beyond the vesting schedules of the RSUs and stock options.

Industry Context

This type of equity compensation is standard practice for publicly traded companies to incentivize and retain key executives. It aligns executive compensation with shareholder value.

Comparison to Industry Standards

• Equity grants are a common component of executive compensation packages in the healthcare and pharmaceutical industries.
• Companies like Johnson & Johnson, Novartis, and AbbVie also utilize stock options and RSUs to incentivize their executives.
• The vesting schedules and terms of these grants are generally comparable across the industry, with three-year vesting being a common practice.

Stakeholder Impact

• Shareholders may view the equity grants positively as they incentivize management to improve company performance.
• Employees may see this as a positive sign of investment in leadership.

Key Dates